Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05259319
Title	Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT) (IMMUNOs-SBRT)
Acronym	IMMUNOs-SBRT
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Centre Georges Francois Leclerc
Indications	head and neck carcinoma lung non-small cell carcinoma renal cell carcinoma urinary bladder cancer
Therapies	Atezolizumab + Tiragolumab
Age Groups:	adult \| senior
Covered Countries	FRA